Obsessive Compulsive Disorder, Response to Serotonin Reuptake Inhibitors and the Serotonin Transporter Gene

Molecular Psychiatry - United Kingdom
doi 10.1038/sj.mp.4000257
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Augmenting Selective Serotonin Reuptake Inhibitors With Clomipramine in Obsessive-Compulsive Disorder: Benefits and Risks

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2013English

Memantine Augmentation Improves Symptoms in Serotonin Reuptake Inhibitor-Refractory Obsessive-Compulsive Disorder: A Randomized Controlled Trial

Pharmacopsychiatry
MedicinePsychiatryMental HealthPharmacology
2017English

Selective Serotonin Reuptake Inhibitors.

BMJ
1992English

Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors and Migraine: Should Cochrane Close the Door?

Journal of Biomedical Science and Engineering
2018English

A Double-Blind, Placebo-Controlled Study of Risperidone Addition in Serotonin Reuptake Inhibitor–Refractory Obsessive-Compulsive Disorder

Archives of General Psychiatry
2000English

Serotonin Noradrenaline Reuptake Inhibitors (SNRIs)

2012English

Selective Serotonin Reuptake Inhibitors Induced Serotonin Syndrome –A Case Report

International Journal of Hospital Pharmacy
2017English

Randomized, Single Blinded Comparative Study of Selective Serotonin Reuptake Inhibitor Augmentation With Olanzapine v/S Amisulpride for Obsessive Compulsive Disorder

International Journal of Basic & Clinical Pharmacology
2019English

Serotonin Transporter Gene Regulatory Region Polymorphism and Panic Disorder

Molecular Psychiatry
PsychiatryMolecular NeuroscienceMental HealthMolecular BiologyCellular
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy